Pelvic Floor Rehabilitation Device Market Size, Share, Growth, and Industry Analysis, By Types (Biofeedback Type, Apps and Games Type, Kegel Balls Type, Electrical Stimulation Type, Magnetic Stimulation Type), By Applications (Hospital, Clinic, Home, Others) , and Regional Insights and Forecast to 2034

Pelvic Floor Rehabilitation Device Market Size

The Global Pelvic Floor Rehabilitation Device Market size was USD 1.94 billion in 2024 and is projected to reach USD 2.23 billion in 2025, USD 2.57 billion in 2026, and USD 7.97 billion by 2034, exhibiting a 15.2% growth rate during the forecast period (2025–2034). The demand is strongly influenced by rising awareness, with over 40% of women experiencing pelvic health issues and nearly 25% of men requiring rehabilitation support after medical procedures, creating a strong pathway for continued adoption.

The US Pelvic Floor Rehabilitation Device Market is expected to grow significantly, supported by a 45% prevalence of pelvic floor disorders among women and nearly 30% of men facing post-surgical complications. More than 55% of hospitals in the country have integrated advanced pelvic floor rehabilitation technologies, and nearly 50% of patients prefer home-based devices. Strong awareness campaigns and clinical recommendations have increased adoption by more than 40%, making the US one of the leading markets for pelvic floor rehabilitation devices.

Key Findings

• Market Size: The market expanded from USD 1.94 billion in 2024 to USD 2.23 billion in 2025, projected at USD 7.97 billion by 2034, growing 15.2%.
• Growth Drivers: More than 40% women with pelvic disorders, 25% men with dysfunctions, and 55% hospitals equipped with rehabilitation devices drive adoption.
• Trends: Over 70% patients using stimulation devices report improvements, 30% adoption of home-based solutions, and 45% rise in digital therapy engagement.
• Key Players: Laborie, Atlantic Therapeutics, Elvie Trainer, Kegel8, Perifit & more.
• Regional Insights: North America holds 38% share driven by advanced healthcare adoption, Europe captures 27% with strong clinical programs, Asia-Pacific accounts for 25% through rising awareness, and Middle East & Africa contributes 10% supported by growing urban healthcare facilities, together forming 100% market share.
• Challenges: More than 40% patients face affordability issues, 60% lack insurance coverage, and 55% in emerging markets remain unaware of therapies.
• Industry Impact: Over 50% growth driven by awareness, 35% from smart devices, and 25% through home-use adoption transforming pelvic healthcare.
• Recent Developments: More than 40% of new devices feature gamification, 30% smart integration, and 25% wearable innovations enhancing user compliance.

The Pelvic Floor Rehabilitation Device Market is evolving rapidly with technology integration, consumer adoption, and healthcare awareness fueling demand. With 65% of physiotherapists recommending device-based therapies and nearly 50% of patients opting for at-home solutions, the market is diversifying in scope. Non-invasive solutions such as magnetic stimulation and gamified training modules are gaining traction, improving compliance by over 35%. Manufacturers are increasingly focusing on digitalization, with more than 40% of new devices connected to apps for enhanced monitoring, supporting long-term patient rehabilitation outcomes.

Pelvic Floor Rehabilitation Device Market Trends

The pelvic floor rehabilitation device market is witnessing significant adoption due to the rising prevalence of urinary incontinence and pelvic organ prolapse. Reports indicate that nearly 40% of women globally experience some form of urinary incontinence, creating a high demand for effective pelvic floor strengthening solutions. Additionally, over 25% of men face pelvic floor dysfunction-related conditions post-surgery, further fueling device adoption across healthcare facilities. Non-invasive pelvic floor therapies now account for more than 55% of treatments, with biofeedback devices representing a fast-growing share due to ease of use. Clinical studies highlight that more than 70% of women using electrical stimulation devices reported improved pelvic muscle control within months of treatment. Moreover, home-based rehabilitation devices are gaining momentum, with adoption rates increasing by 30% as patients prefer convenient and discreet solutions. Awareness campaigns and health education initiatives have also led to a 45% rise in consultations related to pelvic health. The growing integration of advanced digital technologies, such as mobile app-connected devices, accounts for over 20% of newly launched products, making the market more patient-centric and accessible.

Pelvic Floor Rehabilitation Device Market Dynamics

OPPORTUNITY

Growing adoption of home-use rehabilitation devices

Home-use pelvic floor rehabilitation devices are rapidly gaining acceptance, with adoption levels growing by more than 30% among women seeking non-invasive treatments. Around 65% of patients prefer using connected smart devices for continuous monitoring and progress tracking, making this an untapped growth opportunity. Furthermore, awareness programs have contributed to a 50% increase in demand across urban healthcare facilities, creating strong potential for device manufacturers to expand market penetration.

DRIVERS

Rising prevalence of pelvic floor disorders

Nearly 40% of women and 25% of men suffer from pelvic floor dysfunctions, significantly driving the demand for rehabilitation devices. Around 70% of clinical practitioners recommend device-based therapies, particularly biofeedback and electrical stimulation devices, to restore pelvic muscle strength. Additionally, awareness initiatives have increased patient participation in preventive healthcare by more than 45%, positioning pelvic floor rehabilitation devices as a primary solution to tackle growing pelvic health concerns worldwide.

RESTRAINTS

"Limited awareness in emerging regions"

Despite growing acceptance in developed economies, more than 55% of women in emerging regions remain unaware of pelvic floor rehabilitation solutions. Only 20% of healthcare centers in rural areas currently provide specialized devices for pelvic muscle therapy. Cost barriers also play a role, with 35% of patients avoiding treatments due to affordability challenges, which restricts widespread adoption of these devices in low-income regions.

CHALLENGE

"High device cost and limited reimbursement policies"

The cost of advanced pelvic floor rehabilitation devices poses a significant challenge, with more than 40% of patients unable to afford long-term therapies. Additionally, nearly 60% of insurance providers do not fully cover device-based treatments, limiting accessibility for middle and lower-income patients. This lack of reimbursement, combined with financial constraints, continues to act as a hurdle for large-scale adoption of pelvic floor rehabilitation devices across healthcare systems globally.

Segmentation Analysis

The global pelvic floor rehabilitation device market, valued at USD 1.94 Billion in 2024, is projected to reach USD 2.23 Billion in 2025 and USD 7.97 Billion by 2034, growing at a CAGR of 15.2% during the forecast period. By type, biofeedback devices accounted for a significant portion with an estimated USD 0.72 Billion in 2025, holding nearly 32% share and expected to grow at a CAGR of 14.8%. Apps and games-based pelvic training devices represented USD 0.40 Billion in 2025, capturing 18% of the market with a CAGR of 16.5%. Kegel balls are projected at USD 0.30 Billion in 2025, holding 13% share, and growing steadily at a CAGR of 14.2%. Electrical stimulation devices represented USD 0.55 Billion in 2025, with a 25% share and a CAGR of 15.9%. Magnetic stimulation devices accounted for USD 0.26 Billion in 2025, holding 12% of the market and expanding at a CAGR of 14.7%. By application, hospitals dominated the market with USD 0.80 Billion in 2025, securing a 36% share, while clinics accounted for USD 0.58 Billion with 26% share, home usage contributed USD 0.62 Billion with 28% share, and others held USD 0.23 Billion with 10% share. Each segment shows robust potential for growth, driven by awareness, technology integration, and rising pelvic health concerns.

By Type

Biofeedback Type

Biofeedback devices are widely utilized as they help patients track muscle contraction and relaxation with precise data. Around 65% of physiotherapists recommend biofeedback for pelvic floor rehabilitation, and more than 50% of patients show faster recovery with consistent use.

Biofeedback Type held the largest share in the pelvic floor rehabilitation device market, accounting for USD 0.72 Billion in 2025, representing 32% of the total market. This segment is expected to grow at a CAGR of 14.8% from 2025 to 2034, driven by clinical adoption, digital monitoring, and home-based applications.

Top 3 Major Dominant Countries in the Biofeedback Type Segment

• United States led the Biofeedback Type segment with a market size of USD 0.25 Billion in 2025, holding a 34% share and expected to grow at a CAGR of 15.0% due to advanced healthcare infrastructure and patient adoption.
• Germany held USD 0.12 Billion in 2025, with a 16% share and projected CAGR of 14.6% supported by strong clinical programs and reimbursement structures.
• Japan reached USD 0.10 Billion in 2025, with a 14% share and anticipated CAGR of 14.5% driven by rising pelvic health awareness and device innovation.

Apps and Games Type

Apps and games-based pelvic training solutions are gaining traction, especially among younger women and tech-savvy patients. More than 45% of users report improved adherence to therapy programs through gamified exercises and digital tracking.

Apps and Games Type recorded USD 0.40 Billion in 2025, accounting for 18% of the market, and is expected to expand at a CAGR of 16.5% from 2025 to 2034, supported by mobile integration, patient engagement, and telehealth expansion.

Top 3 Major Dominant Countries in the Apps and Games Type Segment

• United States held USD 0.15 Billion in 2025, with a 37% share and expected CAGR of 17% driven by tech adoption and digital healthcare policies.
• United Kingdom held USD 0.08 Billion in 2025, with a 20% share and CAGR of 16.2% fueled by national health programs encouraging digital health.
• China held USD 0.07 Billion in 2025, with an 18% share and CAGR of 16.8% due to growing smartphone penetration and increasing pelvic care awareness.

Kegel Balls Type

Kegel balls remain a popular choice for pelvic floor strengthening, especially among women for postpartum recovery. Surveys indicate that nearly 40% of women prefer using Kegel balls as a low-cost, non-invasive solution for pelvic strengthening.

Kegel Balls Type achieved USD 0.30 Billion in 2025, representing 13% of the market share, and is expected to grow at a CAGR of 14.2% from 2025 to 2034, supported by rising consumer health awareness and retail adoption.

Top 3 Major Dominant Countries in the Kegel Balls Type Segment

• United States held USD 0.11 Billion in 2025, with a 36% share and CAGR of 14.4% due to wide retail availability and patient preference.
• France held USD 0.06 Billion in 2025, with a 20% share and CAGR of 14.0% driven by lifestyle adoption and postpartum recovery programs.
• India held USD 0.05 Billion in 2025, with a 17% share and CAGR of 14.5% due to growing awareness and low-cost device adoption.

Electrical Stimulation Type

Electrical stimulation devices are considered highly effective, with over 70% of patients showing significant improvements in muscle strength. Hospitals and clinics prefer this type due to clinical validation and structured therapy sessions.

Electrical Stimulation Type accounted for USD 0.55 Billion in 2025, capturing 25% of the market, and is projected to grow at a CAGR of 15.9% during 2025–2034, fueled by strong clinical demand and technological advancements.

Top 3 Major Dominant Countries in the Electrical Stimulation Type Segment

• United States held USD 0.18 Billion in 2025, with a 33% share and CAGR of 16.1% due to clinical adoption and innovation.
• Germany accounted for USD 0.09 Billion in 2025, with 16% share and CAGR of 15.8% from healthcare policy support.
• China reached USD 0.08 Billion in 2025, with 15% share and CAGR of 16.0% due to increasing pelvic health treatments.

Magnetic Stimulation Type

Magnetic stimulation devices are non-invasive and attract patients reluctant to use internal devices. Around 25% of new patients choose magnetic therapies due to reduced discomfort and effective outcomes.

Magnetic Stimulation Type recorded USD 0.26 Billion in 2025, holding 12% of the market share, and is forecasted to expand at a CAGR of 14.7% during 2025–2034, supported by patient comfort and growing adoption in clinics.

Top 3 Major Dominant Countries in the Magnetic Stimulation Type Segment

• United States held USD 0.09 Billion in 2025, with 35% share and CAGR of 14.9% driven by clinical acceptance and reimbursement programs.
• Japan accounted for USD 0.06 Billion in 2025, holding 23% share and CAGR of 14.5% from growing pelvic health awareness.
• South Korea held USD 0.05 Billion in 2025, with 20% share and CAGR of 14.6% supported by tech-driven healthcare adoption.

By Application

Hospital

Hospitals dominate pelvic floor rehabilitation device adoption, with more than 60% of patients seeking treatments in hospital-based programs. Advanced technologies such as electrical and magnetic stimulation are primarily installed in hospitals for specialized care.

Hospital applications held USD 0.80 Billion in 2025, representing 36% of the market, and are expected to grow at a CAGR of 15.4% from 2025 to 2034, driven by advanced facilities, specialist availability, and strong patient inflow.

Top 3 Major Dominant Countries in the Hospital Application Segment

• United States led with USD 0.30 Billion in 2025, holding 38% share and CAGR of 15.6% due to advanced hospital infrastructure.
• Germany accounted for USD 0.12 Billion in 2025, with 15% share and CAGR of 15.3% driven by healthcare system integration.
• Japan recorded USD 0.11 Billion in 2025, with 14% share and CAGR of 15.2% due to strong clinical adoption.

Clinic

Clinics play a crucial role in offering outpatient pelvic rehabilitation services, particularly for biofeedback and Kegel-based therapies. Around 45% of patients prefer visiting clinics due to convenience and lower treatment costs.

Clinic applications accounted for USD 0.58 Billion in 2025, representing 26% of the total market, with an expected CAGR of 15.0% during 2025–2034, supported by rising patient preference and growing urban healthcare centers.

Top 3 Major Dominant Countries in the Clinic Application Segment

• United States held USD 0.20 Billion in 2025, 34% share, with CAGR of 15.1% driven by outpatient care adoption.
• France held USD 0.09 Billion in 2025, 16% share, with CAGR of 14.8% supported by growing women’s health programs.
• China held USD 0.08 Billion in 2025, 14% share, with CAGR of 15.0% due to rapid expansion of private clinics.

Home

Home-based devices are increasingly adopted for privacy and convenience, with 50% of younger women preferring at-home rehabilitation programs. Gamified apps and Kegel devices dominate this segment, making it highly consumer-driven.

Home applications represented USD 0.62 Billion in 2025, holding 28% share, and are expected to grow at a CAGR of 15.8% from 2025 to 2034, supported by consumer awareness, affordability, and digital integration.

Top 3 Major Dominant Countries in the Home Application Segment

• United States accounted for USD 0.22 Billion in 2025, 35% share, CAGR of 16% driven by consumer demand for smart health devices.
• United Kingdom held USD 0.10 Billion in 2025, 16% share, CAGR of 15.5% supported by telehealth expansion.
• China held USD 0.09 Billion in 2025, 14% share, CAGR of 15.6% fueled by growing retail distribution.

Others

Other applications include rehabilitation centers, physiotherapy institutes, and wellness centers that are gradually incorporating pelvic floor therapy. This segment is small but growing, driven by preventive healthcare awareness.

Others accounted for USD 0.23 Billion in 2025, with a 10% market share, and are projected to expand at a CAGR of 14.9% during 2025–2034, supported by educational awareness and community health adoption.

Top 3 Major Dominant Countries in the Others Application Segment

• United States held USD 0.08 Billion in 2025, 34% share, CAGR of 15.0% due to inclusion in rehabilitation centers.
• Germany held USD 0.05 Billion in 2025, 22% share, CAGR of 14.7% driven by wellness initiatives.
• India accounted for USD 0.04 Billion in 2025, 18% share, CAGR of 15.1% from growing physiotherapy centers.

Pelvic Floor Rehabilitation Device Market Regional Outlook

The global pelvic floor rehabilitation device market, valued at USD 1.94 Billion in 2024, is projected to reach USD 2.23 Billion in 2025 and USD 7.97 Billion by 2034, growing at a CAGR of 15.2% during the forecast period. Regional analysis shows North America leading the market with 38% share, followed by Europe at 27%, Asia-Pacific at 25%, and Middle East & Africa contributing 10%. This distribution reflects advanced healthcare adoption in developed markets and rising awareness across emerging regions, with each region demonstrating unique trends, adoption rates, and growth opportunities within pelvic health solutions.

North America

North America dominates the pelvic floor rehabilitation device market due to advanced healthcare infrastructure and high awareness levels. More than 45% of women in the region report pelvic health issues, driving the need for rehabilitation solutions. Around 55% of hospitals in the United States and Canada are already equipped with biofeedback and electrical stimulation devices. Home-use devices also see rapid adoption, with nearly 40% of patients opting for connected smart devices for therapy.

North America held the largest share in the pelvic floor rehabilitation device market, accounting for USD 0.85 Billion in 2025, representing 38% of the total market. This segment is expected to grow steadily from 2025 to 2034, driven by rising pelvic disorder prevalence, advanced technologies, and patient-centric healthcare approaches.

North America - Major Dominant Countries in the Pelvic Floor Rehabilitation Device Market

• United States led the North America region with a market size of USD 0.55 Billion in 2025, holding a 65% share due to advanced clinical adoption and innovation.
• Canada accounted for USD 0.20 Billion in 2025, with a 23% share driven by supportive healthcare programs and patient awareness.
• Mexico held USD 0.10 Billion in 2025, with 12% share supported by growing urban healthcare infrastructure and affordable device penetration.

Europe

Europe shows strong market growth supported by government healthcare policies and awareness campaigns. More than 42% of women in Europe experience urinary incontinence, contributing to device demand. Over 50% of clinics across Western Europe integrate pelvic floor therapies into women’s health services. Rising preference for non-invasive magnetic stimulation devices has also grown by 25% across major countries like Germany, France, and the UK.

Europe accounted for USD 0.60 Billion in 2025, representing 27% of the total market. The region is expanding due to increased focus on preventive health, digital healthcare integration, and growing adoption of outpatient pelvic rehabilitation programs.

Europe - Major Dominant Countries in the Pelvic Floor Rehabilitation Device Market

• Germany held USD 0.18 Billion in 2025, with 30% share, supported by hospital-based rehabilitation and reimbursement policies.
• France accounted for USD 0.14 Billion in 2025, with 23% share driven by lifestyle adoption and postpartum programs.
• United Kingdom held USD 0.12 Billion in 2025, with 20% share supported by women’s health initiatives and device accessibility.

Asia-Pacific

Asia-Pacific is emerging as one of the fastest-growing regions in the pelvic floor rehabilitation device market. Rising awareness and healthcare access have driven a 40% increase in pelvic health consultations across countries like China, Japan, and India. Nearly 35% of women in the region are adopting home-use solutions such as Kegel devices and mobile app-based training, making consumer adoption a key growth factor.

Asia-Pacific accounted for USD 0.56 Billion in 2025, representing 25% of the global market. This region is poised for significant expansion due to rapid urbanization, growing healthcare investment, and increasing acceptance of digital healthcare tools.

Asia-Pacific - Major Dominant Countries in the Pelvic Floor Rehabilitation Device Market

• China led with USD 0.20 Billion in 2025, holding 36% share, supported by urban healthcare adoption and retail expansion.
• Japan accounted for USD 0.15 Billion in 2025, with 27% share, driven by strong pelvic health awareness and technological innovation.
• India held USD 0.11 Billion in 2025, with 20% share, supported by increasing awareness and affordability of home-use devices.

Middle East & Africa

The Middle East & Africa pelvic floor rehabilitation device market is at a developing stage but showing promising growth potential. More than 25% of women in urban areas report pelvic health disorders, creating gradual adoption of devices. Private healthcare facilities are leading in the introduction of electrical and magnetic stimulation technologies. However, limited awareness in rural areas still restricts large-scale expansion.

Middle East & Africa accounted for USD 0.22 Billion in 2025, representing 10% of the global market. Growth is being fueled by urban healthcare initiatives, government health campaigns, and rising private sector investments in women’s health.

Middle East & Africa - Major Dominant Countries in the Pelvic Floor Rehabilitation Device Market

• United Arab Emirates held USD 0.08 Billion in 2025, with 36% share supported by modern healthcare infrastructure and awareness programs.
• Saudi Arabia accounted for USD 0.07 Billion in 2025, with 32% share driven by hospital adoption and private healthcare investments.
• South Africa held USD 0.05 Billion in 2025, with 23% share supported by urban healthcare demand and device accessibility.

List of Key Pelvic Floor Rehabilitation Device Market Companies Profiled

Investment Analysis and Opportunities in Pelvic Floor Rehabilitation Device Market

The pelvic floor rehabilitation device market presents vast opportunities for investors as adoption rates continue to surge. Over 45% of hospitals globally have integrated advanced pelvic floor rehabilitation devices into treatment programs, highlighting a strong institutional base. Around 55% of patients in urban areas prefer non-invasive home-use solutions, creating significant potential for consumer-based investments. Private healthcare facilities have recorded a 35% increase in device installations over the past few years, while awareness campaigns have contributed to nearly 50% rise in patient consultations. With over 60% of device manufacturers investing in connected smart technologies, opportunities remain strong in digital integration, home-use adoption, and expanding into emerging markets where current penetration levels remain below 30%.

New Products Development

New product development in the pelvic floor rehabilitation device market is accelerating, with nearly 40% of manufacturers launching app-connected or smart-enabled solutions. More than 35% of the newly introduced devices focus on home-use applications, catering to rising consumer demand for discreet and convenient rehabilitation methods. Around 30% of companies are incorporating gamified training modules into their devices, improving therapy adherence rates by over 50%. Furthermore, wearable pelvic training devices account for nearly 20% of recent product launches, supported by digital monitoring features. With patient awareness increasing by 45% and healthcare facilities investing more than 25% of budgets into women’s health technologies, product innovation is reshaping the competitive landscape.

Recent Developments

• Atlantic Therapeutics – INNOVO launch expansion: The company expanded its non-invasive pelvic floor device to additional European markets, achieving a 25% increase in consumer adoption within the first quarter of 2024.
• Elvie Trainer – Smart App integration: Elvie introduced new app features for its pelvic trainer, improving therapy engagement rates by 40% among active users in 2024.
• Laborie – Strategic acquisition: Laborie acquired a smaller pelvic device manufacturer, strengthening its market leadership and boosting its market share by 15% in specialized hospital solutions.
• Perifit – Gamified therapy expansion: Perifit launched updated gamification modules, increasing therapy compliance rates by 35% in its user base throughout 2024.
• TensCare – New Kegel device launch: TensCare introduced a portable electrical stimulation unit, which recorded a 28% adoption increase among home-based users during 2024.

Report Coverage

The report on the pelvic floor rehabilitation device market provides comprehensive insights into key growth drivers, restraints, challenges, and opportunities shaping the industry. It highlights market segmentation by type, application, and region, supported by detailed competitive profiling of major manufacturers. SWOT analysis reveals strong opportunities, with over 50% of the growth driven by increasing awareness and adoption of non-invasive solutions. Strengths include innovation, with 40% of companies investing in digital and smart-connected devices. Weaknesses lie in limited awareness, as more than 55% of patients in emerging regions remain unfamiliar with rehabilitation therapies. Opportunities are evident in home-use adoption, with more than 45% of consumers preferring private treatment methods. Challenges include high costs and reimbursement gaps, with nearly 60% of insurance providers not covering device-based therapies. Regional analysis shows North America accounting for 38% of the market, Europe 27%, Asia-Pacific 25%, and Middle East & Africa 10%. The report also emphasizes investment prospects, highlighting that 35% of device manufacturers are actively expanding into emerging economies. With a holistic view, the coverage ensures stakeholders have a clear roadmap for strategic planning, investment, and innovation within this evolving healthcare sector.